Insulin Pump System
The MiniMed™ 640G insulin pump with SmartGuard™ closely mimics the way a healthy pancreas delivers basal insulin to your body. As part of the MiniMed™ system it can guide you towards better control1 by providing advanced protection from hypo events2. All of this with personalised settings to fit your daily life and therapy needs.LEARN MORE
Continuous Glucose Monitoring (CGM) technology tracks glucose levels in your body 24 hours a day. CGM uses a sensor that connects to your MiniMed™ insulin pump giving you early warnings of highs and lows. CGM is clinically proven to lower HbA1c levels1 and reduce the time of hypos3, and aims to improve quality of life.LEARN MORE
The Ascensia Diabetes Care Contour® NEXT LINK 2.4 is the only blood glucose meter with proven accuracy that sends glucose readings wirelessly to your MiniMed™ 640G insulin pump saving you time and effort. It also allows you to discretely send a bolus directly to your pump and to conveniently download blood glucose and insulin information to CareLink™ Personal, our cloud based therapy management software.LEARN MORE
Our infusion sets with the unique MiniMed™ connection are designed to provide a more secure insulin delivery from your insulin pump to your body. We offer a wide portfolio of different infusion sets to meet your lifestyle needs and body type. Feel comfortable and safe anytime!LEARN MORE
CareLink™ Personal Software is a convenient online tool that accurately tracks your insulin usage and glucose levels, allowing you to compare any changes in glucose levels with your daily activities, such as meals and exercise routines. Clear charts and graphs show you these changes and help you and your diabetes healthcare team discover patterns and adjust your therapy for better control.LEARN MORE
If you would like to learn more about the MiniMed™ system, leave us your details and we will get in touch with you.
- Compared to multiple daily injections, according to the STAR 3 clinical study: Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363:311–320
- Garg S, Brazg RL, Bailey TS , et al. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. Diabetes Tech Ther. 2012;14(3):205-209.
- Section 8 clinical study. Data on File. Bayer Healthcare, LLC.
* Waterproof at time of manufacture up to 3.6 meters for up to 24 hours at a time. See MiniMed™ 640G User Guide for a complete description of the waterproof capabilities and proper use instructions
*** The dynamic resume feature is based on certain preset criteria: sensor glucose must be 1.1 mmol/l above the preset low limit and predicted to be 2.2mmol/l above within 30 minutes AND insulin must have been suspended for at least 30 minutes.